987.80
-0.69%
ICICI Securities Limited
Vijaya Diagnostic Centre’s (Vijaya) Q2FY24 result was a beat vs our estimates driven by 18.3% YoY growth in non-covid business. Test volume growth remained healthy at 18.7% YoY. In Q2, it commercialised a new hub in Kolkata; the company is witnessing good traction and expects the hub to breakeven in next three quarters.
Promoters initiated pledges of 1.48% of holdings in Dec 2025 qtr.
More from Vijaya Diagnostic Centre Ltd.
Recommended